+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sustained Release Injectables Market by Product Type (Cartridges, Implantable Pumps, Pre-Filled Syringes), Polymer Type (Biodegradable Polymers, Non-Biodegradable Polymers), Route Of Administration, Application, End User - Global Forecast 2025-2030- Product Image
Sustained Release Injectables Market by Product Type (Cartridges, Implantable Pumps, Pre-Filled Syringes), Polymer Type (Biodegradable Polymers, Non-Biodegradable Polymers), Route Of Administration, Application, End User - Global Forecast 2025-2030- Product Image
Sale

Sustained Release Injectables Market by Product Type (Cartridges, Implantable Pumps, Pre-Filled Syringes), Polymer Type (Biodegradable Polymers, Non-Biodegradable Polymers), Route Of Administration, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5533434
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The sustained release injectables market is rapidly transforming delivery practices across healthcare, driven by innovation in formulation science and an evolving need for patient-centric treatment solutions. Senior decision-makers are reconsidering portfolio strategies and supply chain approaches as the sector adapts to shifts in regulatory, technological, and economic environments.

Market Snapshot: Sustained Release Injectables at a Glance

The sustained release injectables market grew from USD 2.29 billion in 2024 to USD 2.45 billion in 2025. It is expected to continue expanding at a CAGR of 7.04%, reaching USD 3.45 billion by 2030. Prolonged drug activity and reduced dosing frequencies, enabled by advancements in controlled release technologies, are key drivers accelerating adoption within chronic disease management and personalized medicine frameworks. As a result, pharmaceutical developers, technology suppliers, and healthcare providers are prioritizing solutions that combine therapeutic efficacy with patient convenience.

Scope & Segmentation: Key Dimensions Defining the Sustained Release Injectables Market

  • Product Types: Cartridges, implantable pumps, pre-filled syringes, and unfilled vials, each lending unique advantages in workflow optimization, compounding, and infusion management.
  • Polymer Types: Biodegradable polymers like PCL, PLA, and PLGA, characterized by controlled degradation and safe elimination; non-biodegradable polymers such as polyethylene and polysiloxanes, providing structural support for longer-term implants.
  • Routes of Administration: Epidural, intramuscular, intravitreal, and subcutaneous approaches, allowing targeted delivery and supporting trends toward patient self-administration.
  • Applications: Hormonal therapies, oncology (including hematological malignancies and solid tumors such as breast and lung cancer), pain management, and vaccines.
  • End Users: Ambulatory surgical centers, clinics, home healthcare, and hospitals, each with distinct requirements for storage, quality assurance, and administration protocols.
  • Geographic Regions: Americas (including United States, Canada, Brazil, Mexico, Argentina), Europe, Middle East, and Africa (over 20 key countries), and Asia-Pacific (spanning major and emerging biopharma markets from China to Singapore), reflecting both established and rapidly-growing demand profiles.

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • The sustained release injectables market is shaped by the convergence of advanced polymer science and next-generation drug delivery devices, supporting targeted and patient-friendly treatment regimens.
  • Cross-industry collaborations involving pharmaceutical firms, biotech innovators, device manufacturers, and technology partners are accelerating the co-development of smart injectables and combination products.
  • Adoption of digital health tools—including connected dosing devices and remote adherence monitoring—is enabling healthcare providers to introduce new value-based care models.
  • Regional variations in regulatory frameworks and local manufacturing capacities present both opportunities and logistical challenges, requiring adaptive commercialization and supply chain strategies.
  • Segment-specific innovation, such as programmable implantable pumps and customizable release profiles, supports differentiation and aligns with shifting clinical guidelines in areas like oncology and chronic disease management.

Tariff Impact: Navigating Recent Policy Changes

United States tariff policies implemented in 2025 have raised the complexity of sourcing raw materials and managing supply chain costs. Contract development and manufacturing organizations are adjusting their procurement strategies, seeking tariff-exempt suppliers and increasing resilience through localized production. Rising transportation and logistics expenses are influencing both acquisition cost structures and value-based arrangements with payers. Manufacturers are responding by expanding in-country fill-finish operations and forging partnerships aimed at maintaining supply chain continuity and market accessibility.

Methodology & Data Sources

This report integrates insights from qualitative interviews with senior executives across the pharmaceutical, polymer, device, and healthcare ecosystems. Primary research is complemented by site visits to advanced manufacturing sites and academic labs. Secondary data—including peer-reviewed journals, regulatory guidelines, patent filings, and trade statistics—is validated using triangulation and consultation with external subject-matter experts. This ensures thorough, reliable, and actionable findings.

Sustained Release Injectables Market: Why This Report Matters

  • Gain actionable intelligence to drive innovation investments in platform technologies and modular delivery systems, positioning portfolios for future clinical requirements.
  • Understand how evolving regulatory policies, supply chain strategies, and digital health integrations collectively shape market opportunities and competitive positioning.
  • Support data-driven decisions for geographic expansion and collaborative initiatives by leveraging segmented insights across applications, routes of administration, and end user dynamics.

Conclusion

The evolving sustained release injectables market calls for integrated innovation, adaptive operations, and cross-sector collaboration. Stakeholders prepared to align technology adoption with region-specific strategies will be positioned to deliver more effective, accessible, and patient-centric therapeutic solutions.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advancements in biodegradable polymer carriers enabling ultra-long sustained release profiles
5.2. Integration of on-body wearable injectors for patient-controlled long-acting drug delivery without clinic visits
5.3. Development of next-generation microsphere formulations to improve stability and reduce burst release effects
5.4. Emergence of long-acting antibody therapies using sustained release depots for chronic disease management
5.5. Regulatory harmonization and accelerated approval pathways for novel sustained release injectable products
5.6. Adoption of digital health technologies for remote monitoring of implantable sustained release systems
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Sustained Release Injectables Market, by Product Type
8.1. Introduction
8.2. Cartridges
8.3. Implantable Pumps
8.4. Pre-Filled Syringes
8.5. Unfilled Vials
9. Sustained Release Injectables Market, by Polymer Type
9.1. Introduction
9.2. Biodegradable Polymers
9.2.1. PCL
9.2.2. PLA
9.2.3. PLGA
9.3. Non-Biodegradable Polymers
9.3.1. Polyethylene
9.3.2. Polysiloxanes
10. Sustained Release Injectables Market, by Route Of Administration
10.1. Introduction
10.2. Epidural
10.3. Intramuscular
10.4. Intravitreal
10.5. Subcutaneous
11. Sustained Release Injectables Market, by Application
11.1. Introduction
11.2. Hormonal Therapies
11.3. Oncology
11.3.1. Hematological Malignancies
11.3.2. Solid Tumors
11.3.2.1. Breast Cancer
11.3.2.2. Lung Cancer
11.4. Pain Management
11.5. Vaccines
12. Sustained Release Injectables Market, by End User
12.1. Introduction
12.2. Ambulatory Surgical Centers
12.3. Clinics
12.4. Home Healthcare
12.5. Hospitals
13. Americas Sustained Release Injectables Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Sustained Release Injectables Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Sustained Release Injectables Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Johnson & Johnson
16.3.2. Novartis AG
16.3.3. Pfizer Inc.
16.3.4. F. Hoffmann-La Roche Ltd
16.3.5. Sanofi S.A.
16.3.6. GlaxoSmithKline plc
16.3.7. AbbVie Inc.
16.3.8. Abbott Laboratories
16.3.9. Amgen Inc.
16.3.10. Baxter International Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. SUSTAINED RELEASE INJECTABLES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. SUSTAINED RELEASE INJECTABLES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. SUSTAINED RELEASE INJECTABLES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. SUSTAINED RELEASE INJECTABLES MARKET: RESEARCHAI
FIGURE 26. SUSTAINED RELEASE INJECTABLES MARKET: RESEARCHSTATISTICS
FIGURE 27. SUSTAINED RELEASE INJECTABLES MARKET: RESEARCHCONTACTS
FIGURE 28. SUSTAINED RELEASE INJECTABLES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. SUSTAINED RELEASE INJECTABLES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY CARTRIDGES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY CARTRIDGES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY IMPLANTABLE PUMPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY IMPLANTABLE PUMPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRE-FILLED SYRINGES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRE-FILLED SYRINGES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY UNFILLED VIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY UNFILLED VIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PCL, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PCL, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PLA, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PLA, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PLGA, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PLGA, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYETHYLENE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYSILOXANES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYSILOXANES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY EPIDURAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY EPIDURAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY INTRAVITREAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY INTRAVITREAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY HORMONAL THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY HORMONAL THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 121. CANADA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 122. CANADA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 123. CANADA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2024 (USD MILLION)
TABLE 124. CANADA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2025-2030 (USD MILLION)
TABLE 125. CANADA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2024 (USD MILLION)
TABLE 126. CANADA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2025-2030 (USD MILLION)
TABLE 127. CANADA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2024 (USD MILLION)
TABLE 128. CANADA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2025-2030 (USD MILLION)
TABLE 129. CANADA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 130. CANADA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 131. CANADA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 132. CANADA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 133. CANADA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 134. CANADA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 135. CANADA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 136. CANADA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 137. CANADA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. CANADA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. MEXICO SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 140. MEXICO SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 141. MEXICO SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2024 (USD MILLION)
TABLE 142. MEXICO SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2025-2030 (USD MILLION)
TABLE 143. MEXICO SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2024 (USD MILLION)
TABLE 144. MEXICO SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2025-2030 (USD MILLION)
TABLE 145. MEXICO SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2024 (USD MILLION)
TABLE 146. MEXICO SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2025-2030 (USD MILLION)
TABLE 147. MEXICO SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 148. MEXICO SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 149. MEXICO SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. MEXICO SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. MEXICO SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 152. MEXICO SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 153. MEXICO SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 154. MEXICO SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 155. MEXICO SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. MEXICO SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. GERMANY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 232. GERMANY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 233. GERMANY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2024 (USD MILLION)
TABLE 234. GERMANY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2025-2030 (USD MILLION)
TABLE 235. GERMANY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2024 (USD MILLION)
TABLE 236. GERMANY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2025-2030 (USD MILLION)
TABLE 237. GERMANY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2024 (USD MILLION)
TABLE 238. GERMANY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2025-2030 (USD MILLION)
TABLE 239. GERMANY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 240. GERMANY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 241. GERMANY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 242. GERMANY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 243. GERMANY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 244. GERMANY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 245. GERMANY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 246. GERMANY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 247. GERMANY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. GERMANY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. FRANCE SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 250. FRANCE SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 251. FRANCE SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2024 (USD MILLION)
TABLE 252. FRANCE SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2025-2030 (USD MILLION)
TABLE 253. FRANCE SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2024 (USD MILLION)
TABLE 254. FRANCE SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2025-2030 (USD MILLION)
TABLE 255. FRANCE SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2024 (USD MILLION)
TABLE 256. FRANCE SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2025-2030 (USD MILLION)
TABLE 257. FRANCE SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 258. FRANCE SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 259. FRANCE SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 260. FRANCE SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 261. FRANCE SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 262. FRANCE SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 263. FRANCE SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 264. FRANCE SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 265. FRANCE SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. FRANCE SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2025-2030 (USD MILLION)
TABLE 273. RUSSIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2024 (USD MILLION)
TABLE 274. RUSSIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2025-2030 (USD MILLION)
TABLE 275. RUSSIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 276. RUSSIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 277. RUSSIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 278. RUSSIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 279. RUSSIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 280. RUSSIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 281. RUSSIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 282. RUSSIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 283. RUSSIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. RUSSIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. ITALY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 286. ITALY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 287. ITALY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2024 (USD MILLION)
TABLE 288. ITALY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2025-2030 (USD MILLION)
TABLE 289. ITALY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2024 (USD MILLION)
TABLE 290. ITALY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2025-2030 (USD MILLION)
TABLE 291. ITALY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2024 (USD MILLION)
TABLE 292. ITALY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2025-2030 (USD MILLION)
TABLE 293. ITALY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 294. ITALY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 295. ITALY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 296. ITALY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 297. ITALY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 298. ITALY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 299. ITALY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 300. ITALY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 301. ITALY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. ITALY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. SPAIN SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 201

Samples

Loading
LOADING...

Companies Mentioned

  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • F. Hoffmann-La Roche Ltd
  • Sanofi S.A.
  • GlaxoSmithKline plc
  • AbbVie Inc.
  • Abbott Laboratories
  • Amgen Inc.
  • Baxter International Inc.

Table Information

Report AttributeDetails
No. of Pages185
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.45 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.45 Billion
Compound Annual Growth Rate7.0%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Injectable Hydrogels Market by Type (Hybrid, Natural, Synthetic), Application (Cardiovascular, Drug Delivery, Ophthalmology), Crosslinking Mechanism, Route Of Administration, End User - Global Forecast 2025-2030 - Product Image

Injectable Hydrogels Market by Type (Hybrid, Natural, Synthetic), Application (Cardiovascular, Drug Delivery, Ophthalmology), Crosslinking Mechanism, Route Of Administration, End User - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Generic Injectables: Market Share, and Growth Analysis by Product Type (Powder Injectables, Liquid Injectables, Pre-filled Syringes), Application, End User, Technology - Product Image

Generic Injectables: Market Share, and Growth Analysis by Product Type (Powder Injectables, Liquid Injectables, Pre-filled Syringes), Application, End User, Technology

  • Report
  • 150 Pages
  • Global
From
Injectable Cytotoxic Drugs - Global Strategic Business Report - Product Image

Injectable Cytotoxic Drugs - Global Strategic Business Report

  • Report
  • 380 Pages
  • Global
From
Injectable Drugs Market by Molecule Type (Large Molecule, Small Molecule), Drug Class (Anesthetics, Anti-Infective Drugs, Blood Factors / Coagulation), Category, Route Of Administration, Therapeutic Applications, End Users - Global Forecast 2025-2030 - Product Image

Injectable Drugs Market by Molecule Type (Large Molecule, Small Molecule), Drug Class (Anesthetics, Anti-Infective Drugs, Blood Factors / Coagulation), Category, Route Of Administration, Therapeutic Applications, End Users - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Injectable Drug Delivery Devices Market - Product Image

Injectable Drug Delivery Devices Market

  • Report
  • 166 Pages
  • Global
From

About the Sustained Release Injectable Market

The Sustained Release Injectable market is a subset of the Infusions and Injectables market. It is composed of drugs that are administered via injection and are designed to provide a slow and steady release of the active ingredient over a period of time. This type of drug delivery system is beneficial for patients who require a consistent level of medication over a long period of time. It also reduces the number of injections needed, which can be beneficial for patients who have difficulty with frequent injections. The Sustained Release Injectable market is composed of a variety of drugs, including hormones, antibiotics, and analgesics. These drugs are typically administered via intramuscular or subcutaneous injection, and the active ingredient is slowly released over a period of time. Some companies in the Sustained Release Injectable market include Pfizer, Merck, Novartis, and Sanofi. These companies produce a variety of drugs that are designed to provide a slow and steady release of the active ingredient over a period of time. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.